120 related articles for article (PubMed ID: 38690653)
1. Counteracting Angiotensinogen Small-Interfering RNA-Mediated Antihypertensive Effects With REVERSIR.
Ye D; Cruz-López EO; Veghel RV; Garrelds IM; Kasper A; Wassarman K; Tu HC; Zlatev I; Danser AHJ
Hypertension; 2024 Jul; 81(7):1491-1499. PubMed ID: 38690653
[TBL] [Abstract][Full Text] [Related]
2. Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen.
Uijl E; Mirabito Colafella KM; Sun Y; Ren L; van Veghel R; Garrelds IM; de Vries R; Poglitsch M; Zlatev I; Kim JB; Hoorn EJ; Foster D; Danser AHJ
Hypertension; 2019 Jun; 73(6):1249-1257. PubMed ID: 31030610
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes.
Cruz-López EO; Ren L; Uijl E; Clahsen-van Groningen MC; van Veghel R; Garrelds IM; Domenig O; Poglitsch M; Zlatev I; Rooney T; Kasper A; Nioi P; Foster D; Danser AHJ
Br J Pharmacol; 2023 Jan; 180(1):80-93. PubMed ID: 36106615
[TBL] [Abstract][Full Text] [Related]
4. Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension.
Olearczyk J; Gao S; Eybye M; Yendluri S; Andrews L; Bartz S; Cully D; Tadin-Strapps M
Hypertens Res; 2014 May; 37(5):405-12. PubMed ID: 24335718
[TBL] [Abstract][Full Text] [Related]
5. Conventional Vasopressor and Vasopressor-Sparing Strategies to Counteract the Blood Pressure-Lowering Effect of Small Interfering RNA Targeting Angiotensinogen.
Uijl E; Ye D; Ren L; Mirabito Colafella KM; van Veghel R; Garrelds IM; Lu HS; Daugherty A; Hoorn EJ; Nioi P; Foster D; Danser AHJ
J Am Heart Assoc; 2022 Aug; 11(15):e026426. PubMed ID: 35876413
[TBL] [Abstract][Full Text] [Related]
6. Blood Pressure Lowering and Safety Improvements With Liver Angiotensinogen Inhibition in Models of Hypertension and Kidney Injury.
Mullick AE; Yeh ST; Graham MJ; Engelhardt JA; Prakash TP; Crooke RM
Hypertension; 2017 Sep; 70(3):566-576. PubMed ID: 28716988
[TBL] [Abstract][Full Text] [Related]
7. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
[TBL] [Abstract][Full Text] [Related]
8. Targeting Angiotensinogen With
Ye D; Cruz-López EO; Tu HC; Zlatev I; Danser AHJ
Arterioscler Thromb Vasc Biol; 2023 Dec; 43(12):2256-2264. PubMed ID: 37855126
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligodeoxynucleotides directed against a novel angiotensinogen mRNA-stabilizing protein reduce blood pressure in spontaneously hypertensive rats.
Klett CP; Anderson D; Sholook M; Granger JP
Am J Physiol Regul Integr Comp Physiol; 2004 Sep; 287(3):R619-26. PubMed ID: 15155278
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotides targeting angiotensinogen: insights from animal studies.
Wu CH; Wang Y; Ma M; Mullick AE; Crooke RM; Graham MJ; Daugherty A; Lu HS
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30530571
[TBL] [Abstract][Full Text] [Related]
11. Effects of the novel nonsteroidal mineralocorticoid receptor blocker, esaxerenone (CS-3150), on blood pressure and urinary angiotensinogen in low-renin Dahl salt-sensitive hypertensive rats.
Li L; Guan Y; Kobori H; Morishita A; Kobara H; Masaki T; Nakano D; Nishiyama A
Hypertens Res; 2019 Jun; 42(6):769-778. PubMed ID: 30587856
[TBL] [Abstract][Full Text] [Related]
12. Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
Wagner J; Drab M; Bohlender J; Amann K; Wienen W; Ganten D
Clin Exp Hypertens; 1998 Feb; 20(2):205-21. PubMed ID: 9533614
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice.
Ying J; Stuart D; Hillas E; Gociman BR; Ramkumar N; Lalouel JM; Kohan DE
Am J Hypertens; 2012 Jun; 25(6):684-9. PubMed ID: 22378037
[TBL] [Abstract][Full Text] [Related]
14. Novel Pharmacological Approaches in the Treatment of Hypertension: A Focus on RNA-Based Therapeutics.
Addison ML; Ranasinghe P; Webb DJ
Hypertension; 2023 Nov; 80(11):2243-2254. PubMed ID: 37706295
[TBL] [Abstract][Full Text] [Related]
15. No evidence for brain renin-angiotensin system activation during DOCA-salt hypertension.
Uijl E; Ren L; Mirabito Colafella KM; van Veghel R; Garrelds IM; Domenig O; Poglitsch M; Zlatev I; Kim JB; Huang S; Melton L; Hoorn EJ; Foster D; Danser AHJ
Clin Sci (Lond); 2021 Jan; 135(2):259-274. PubMed ID: 33404046
[TBL] [Abstract][Full Text] [Related]
16. Reduction of plasma angiotensin II to normal levels by antisense oligodeoxynucleotides against liver angiotensinogen cannot completely attenuate vascular remodeling in spontaneously hypertensive rats.
Sugano M; Tsuchida K; Sawada S; Makino N
J Hypertens; 2000 Jun; 18(6):725-31. PubMed ID: 10872557
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-mediated RNA interference of angiotensinogen decreases blood pressure and improves myocardial remodeling in spontaneously hypertensive rats.
Yuan LF; Sheng J; Lu P; Wang YQ; Jin T; Du Q
Mol Med Rep; 2015 Sep; 12(3):4657-4663. PubMed ID: 26062941
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
[TBL] [Abstract][Full Text] [Related]
19. [Up-regulation of intrarenal renin-angiotensin system contributes to renal damage in high-salt induced hypertension rats].
Wu HY; Liang YX; Bai Q; Zhuang Z; A LT; Zheng DX; Wang Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Feb; 47(1):149-54. PubMed ID: 25686347
[TBL] [Abstract][Full Text] [Related]
20. Regulation of angiotensinogen expression by angiotensin II in spontaneously hypertensive rat primary astrocyte cultures.
Gowrisankar YV; Clark MA
Brain Res; 2016 Jul; 1643():51-8. PubMed ID: 27131988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
